Silco Pharmaceuticals Limited (DSE:SILCOPHL)

Market Cap	1.68B
Revenue (ttm)	422.64M
Net Income (ttm)	52.06M
Shares Out	103.81M
EPS (ttm)	0.50
PE Ratio	32.39
Forward PE	n/a
Dividend	0.10 (0.62%)
Ex-Dividend Date	Dec 9, 2024

Volume	274,053
Average Volume	305,765
Open	16.80
Previous Close	16.50
Day's Range	16.10 - 16.80
52-Week Range	15.40 - 23.90
Beta	0.23
RSI	48.30
Earnings Date	Apr 29, 2025

About Silco Pharmaceuticals

Silco Pharmaceuticals Limited engages in manufacturing and marketing of finished pharmaceutical products in Bangladesh and internationally. It offers products in the therapeutic areas of analgesic and antipyretic, anti-platelet, antiasthmatic, antibiotic, antidepressant, antidiabetic, antiemetic, antifungal, antihistamin, antihypertensive and antianginal, antimicrobial, antiprotozoal, antispasmodic, antiulcerant, anxiolytic, calcium and combinations, central muscle relaxants, diuretics, gastroprokinetic, haematinic, vitamins and minerals, laxat...

• Industry: Pharmaceutical Preparations
• Founded: 1995
• Employees: 313
• Stock Exchange: Dhaka Stock Exchange
• Ticker Symbol: SILCOPHL

Financial Performance

In 2024, Silco Pharmaceuticals's revenue was 410.10 million, a decrease of -11.75% compared to the previous year's 464.70 million. Earnings were 45.88 million, a decrease of -33.72%.